(Q38271405)

1 September 2017

1 reference

title

Developments in Tau PET Imaging (English)

1 reference

1 September 2017

4

Pedro Rosa-Neto

1 reference

1 September 2017

Eduardo Rigon Zimmer

1

1 reference

1 September 2017

Antoine Leuzy

series ordinal

2

1 reference

1 September 2017

Serge Gauthier

series ordinal

3

1 reference

1 September 2017

publication date

1 September 2014

1 reference

Canadian Journal of Neurological Sciences

1 September 2017

published in

1 reference

1 September 2017

volume

41

1 reference

1 September 2017

issue

5

1 reference

1 September 2017

page(s)

547-553

1 reference

Post-translational modifications of tau protein: implications for Alzheimer's disease.

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Corticobasal degeneration: a pathologically distinct 4R tauopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

PET radiotracers: crossing the blood-brain barrier and surviving metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

In vitro imaging techniques in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Propagation of tau pathology in a model of early Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Assessing THK523 selectivity for tau deposits in Alzheimer's disease and non-Alzheimer's disease tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Tau pathophysiology in neurodegeneration: a tangled issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

A protein factor essential for microtubule assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Alzheimer disease therapy--moving from amyloid-β to tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Animal models reveal role for tau phosphorylation in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Neuropathology of cognitively normal elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Mutations causing neurodegenerative tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

Visualization of the dynamic instability of individual microtubules by dark-field microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

The pathological process underlying Alzheimer's disease in individuals under thirty

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Use of biomarkers in clinical trials of Alzheimer disease: from concept to application

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

A highly selective and specific PET tracer for imaging of tau pathologies

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Binding Characteristics of Radiofluorinated 6-Dialkylamino-2-Naphthylethylidene Derivatives as Positron Emission Tomography Imaging Probes for β-Amyloid Plaques in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall

1 reference

https://api.crossref.org/works/10.1017%2FCJN.2014.15

7 January 2021

Identifiers

DOI

10.1017/CJN.2014.15

1 reference

1 September 2017

1 reference